Jalili, Ahmad <br/><br/>
Polo-like kinase 1 is a potential therapeutic target in human melanoma.  [electronic resource] 

 -  The Journal of investigative dermatology  Sep 2011 
 - 1886-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2011.136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Cycle Proteins--genetics<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Flavonoids--pharmacology<br/>G1 Phase--physiology<br/>Gene Expression Regulation, Enzymologic--physiology<br/>Gene Expression Regulation, Neoplastic--physiology<br/>Genomics<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Melanoma--genetics<br/>Nevus, Pigmented--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>RNA, Small Interfering--pharmacology<br/>Skin Neoplasms--genetics<br/>Tumor Suppressor Protein p53--metabolism<br/>Polo-Like Kinase 1